Journal for ImmunoTherapy of Cancer (Nov 2021)
453 Personalized DNA neoantigen vaccine (GNOS-PV02) in combination with plasmid IL-12 and pembrolizumab for the treatment of patients with advanced hepatocellular carcinoma
Abstract
No abstracts available.